150 Orphan Drug Indication Approvals Trusted to Calyx IRT August 8, 2022 7:55 am|Trial sponsors rely on Calyx IRT to ensure patient supply during rare disease treatment development
Scott Palladino Joins Obsidian as Chief Business Development Officer August 8, 2022 7:55 am|NEW YORK, Aug. 8, 2022 /PRNewswire/ — Obsidian Insurance Group (“Obsidian”), which is focused on facilitating and supporting…
The United Mexican States Announces New Offering of its Global Notes and Tender Offer August 8, 2022 7:51 am|MEXICO CITY, Aug. 8, 2022 /PRNewswire/ —
Bank Leumi to Report Financials as of June 30, 2022 on August 16, 2022 August 8, 2022 7:46 am|TEL AVIV, Israel, Aug. 8, 2022 /PRNewswire/ — Bank Leumi (TASE: LUMI) announced today that it will release…
Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update August 8, 2022 7:45 am|NEW YORK, Aug. 8, 2022 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on…
Mason Graphite Reports Completion of Black Swan Qualifying Transaction and First Day of Trading August 8, 2022 7:30 am|MONTRÉAL, Aug. 8, 2022 /PRNewswire/ – Mason Graphite Inc. (“Mason Graphite” or the “Company”) (TSXV: LLG) (OTCQX: MGPHF)…
AUXLY TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS ON AUGUST 15, 2022 August 8, 2022 7:30 am|TORONTO, Aug. 8, 2022 /PRNewswire/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a…
Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update August 8, 2022 7:30 am|BERWYN, Pa., Aug. 8, 2022 /PRNewswire/ — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug…